Experts Expect More Speech Protections From FDA During Trump Admin

The ongoing push for less US FDA regulation of speech that is truthful and not misleading should continue through the next several years, experts say.

US FDA may take a slightly more business-friendly bent over the next three and a half years, a panel of experts said at the Food & Drug Law Institute’s Advertising and Promotions conference this week. But they cautioned not to expect any major changes overnight.

In particular, panelists expect progress for companies in gaining broader protection for off-label speech. FDA commissioner Scott Gottlieb signaled support...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation